Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This product is a **sterile intravenous crystalloid and carbohydrate combination solution** containing dextrose monohydrate, sodium lactate, potassium chloride, calcium chloride, and sodium chloride. It is used parenterally as a source of water, electrolytes, and calories, and as an alkalinizing agent. The pharmacologic effect is not mediated by a single receptor target; rather, the formulation restores extracellular fluid volume, replenishes sodium, potassium, calcium, and chloride losses, provides glucose calories through dextrose, and supplies lactate that is metabolized to bicarbonate, helping buffer metabolic acidosis. It is marketed as Lactated Ringer's and 5% Dextrose Injection and related potassium-containing Lactated Ringer's/dextrose presentations, and the provided context identifies ICU Medical as the manufacturer/distributor. The relevant clinical use is fluid and electrolyte replacement in adults and pediatric patients who require intravenous hydration, electrolyte repletion, minimal carbohydrate calories, and alkalinization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextrose monohydrate + sodium lactate + potassium chloride + calcium chloride + sodium chloride.